Bempedoic acid
Esperion
['cardio']
 results of the #clear outcomes trial presented at #acc23 #wcc23 found #bempedoicacid lowered #cholesterol and reduced the risk of serious cardiovascular outcomes in #statin-intolerant patients: 
Editor of Diagnostic and Interventional Cardiology magazine. Subscribe to DAIC at https://t.co/E8pvgxF46h